The molecular basis of hereditary complement factor I deficiency

T J Vyse1, B J Morley, I Bartok

  • 1Department of Medicine, RPMS, Hammersmith Hospital, London, United Kingdom.

Insights

Hereditary complement factor I deficiency results from specific genetic mutations. These mutations impact factor I mRNA, leading to varied clinical presentations, from asymptomatic to recurrent infections.

Area of Science:

  • Immunogenetics
  • Molecular Medicine
  • Biochemistry

Background:

  • Hereditary complement factor I deficiency is a rare genetic disorder affecting the immune system.
  • Complement factor I plays a crucial role in regulating the complement cascade, preventing excessive immune responses.
  • Understanding the molecular basis of this deficiency is key to diagnosing and potentially treating associated infections.

Purpose of the Study:

  • To elucidate the molecular basis of hereditary complement factor I deficiency in two distinct pedigrees.
  • To identify specific genetic mutations responsible for complement factor I deficiency.
  • To correlate genotype with clinical phenotype in affected individuals.

Main Methods:

  • Analysis of complement factor I mRNA using reverse transcription and polymerase chain reaction (RT-PCR).
  • DNA sequencing to identify specific nucleotide substitutions and splice site mutations.
  • Genotyping of affected individuals within two pedigrees.

Main Results:

  • Identified a transversion mutation (adenine to thymine at nucleotide 1282) in both siblings of the first pedigree, leading to a histidine-400 to leucine substitution.
  • The proband of the second pedigree was a compound heterozygote, carrying the same transversion mutation on one allele.
  • The second allele in the second pedigree exhibited a donor splice site mutation, causing the deletion of exon 5 (encoding a low-density lipoprotein receptor domain) from the transcript.

Conclusions:

  • Specific mutations in the complement factor I gene underlie hereditary deficiency.
  • The identified mutations, including a missense mutation and a splice site mutation, disrupt factor I function.
  • Genotype-phenotype correlations highlight the importance of complement factor I in preventing pyogenic infections.

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.1K
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K